| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Sorafenib | FAERS: 14 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | Sunitinib | FAERS: 12 | US FAERS | |
| 3 | Capecitabine | FAERS: 10 | OFFSIDES US FAERS | |
| 4 | regorafenib | FAERS: 7 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 5 | Lamotrigine | FAERS: 4 | US FAERS | |
| 6 | liposomal doxorubicin | FAERS: 4 | US FAERS | |
| 7 | Cabozantinib S-malate | FAERS: 3 | US FAERS | |
| 8 | Alendronate | FAERS: 1 | US FAERS | |
| 9 | Amoxicillin | FAERS: 1 | US FAERS | |
| 10 | Aripiprazole | FAERS: 1 | US FAERS | |
| 11 | CID 129626832 | FAERS: 1 | US FAERS | |
| 12 | Capsaicin | FAERS: 1 | US FAERS | |
| 13 | Doxorubicin | FAERS: 1 | US FAERS | |
| 14 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 15 | Everolimus | FAERS: 1 | US FAERS | |
| 16 | Flecainide | FAERS: 1 | US FAERS | |
| 17 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 18 | Moxifloxacin | FAERS: 1 | US FAERS | |
| 19 | Omacor | FAERS: 1 | US FAERS | |
| 20 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 21 | pazopanib | FAERS: 1 | US FAERS | |
| 22 | salmon calcitonin | FAERS: 1 | US FAERS | |
| 23 | salmon calcitonin | FAERS: 1 | US FAERS | |
| 24 | tofacitinib | FAERS: 1 | US FAERS | |
| 25 | Calcium Compounds | OFFSIDES | ||
| 26 | Dicyclomine | OFFSIDES | ||
| 27 | Lapatinib | OFFSIDES | ||
| 28 | Moxifloxacin | OFFSIDES | ||
| 29 | PCI 32765 | Canada Vigilance: 1 | Canada Vigilance | |
| 30 | Pyridoxine | OFFSIDES | ||
| 31 | Vitamin E | OFFSIDES | ||
| 32 | adefovir dipivoxil | OFFSIDES | ||
| 33 | pazopanib | SIDER |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.